MDR progressing very well and believe they are in now real growth phase after completing implementation phase.
Once supply over through to 4c. This will quickly climb and set to 6c.
MC is very low and it has first mover advantage in AUS & NZ when comes to GP-Pharma apps. Even they can't earn big money from subscription but would be able to earn good revenue from advertising.
Once RAP re-listed, it was held back with some good supply between 2-2.5c. However, since market realized the potential, it just kept climbing.
Not saying MDR will fly like RAP but it has potential to sit around 6-8c until some great financial (Revenue/profit) figures is out.
cheers
J
Ann: MedAdvisor & Arrow to launch strategic partnership, page-7
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
